GOFEN & GLOSSBERG LLC /IL/ - NYMOX PHARMACEUTICAL CORP ownership

NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is P73398102. A total of 58 filers reported holding NYMOX PHARMACEUTICAL CORP in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GOFEN & GLOSSBERG LLC /IL/ ownership history of NYMOX PHARMACEUTICAL CORP
ValueSharesWeighting
Q4 2022$7
-100.0%
25,000
-50.0%
0.00%
-100.0%
Q3 2022$21,000
+90.9%
50,000
+100.0%
0.00%
Q2 2022$11,000
-65.6%
25,0000.0%0.00%
-100.0%
Q1 2022$32,000
-3.0%
25,0000.0%0.00%0.0%
Q4 2021$33,000
-36.5%
25,0000.0%0.00%0.0%
Q3 2021$52,000
+30.0%
25,0000.0%0.00%0.0%
Q2 2021$40,000
-28.6%
25,0000.0%0.00%0.0%
Q1 2021$56,000
-9.7%
25,0000.0%0.00%
-50.0%
Q4 2020$62,0000.0%25,0000.0%0.00%0.0%
Q3 2020$62,000
-30.3%
25,0000.0%0.00%
-33.3%
Q2 2020$89,000
+50.8%
25,0000.0%0.00%
+50.0%
Q1 2020$59,000
+7.3%
25,0000.0%0.00%0.0%
Q4 2019$55,000
+19.6%
25,0000.0%0.00%0.0%
Q3 2019$46,000
+27.8%
25,0000.0%0.00%
+100.0%
Q2 2019$36,000
-26.5%
25,0000.0%0.00%
-50.0%
Q1 2019$49,000
+48.5%
25,0000.0%0.00%
+100.0%
Q4 2018$33,000
-46.8%
25,0000.0%0.00%
-50.0%
Q3 2018$62,000
-26.2%
25,0000.0%0.00%
-33.3%
Q2 2018$84,000
-20.8%
25,0000.0%0.00%
-25.0%
Q1 2018$106,000
+27.7%
25,0000.0%0.00%
+33.3%
Q4 2017$83,000
-13.5%
25,0000.0%0.00%
-25.0%
Q3 2017$96,000
-12.7%
25,0000.0%0.00%0.0%
Q2 2017$110,000
+20.9%
25,0000.0%0.00%0.0%
Q1 2017$91,000
+35.8%
25,0000.0%0.00%
+33.3%
Q4 2016$67,000
-18.3%
25,0000.0%0.00%0.0%
Q3 2016$82,000
-2.4%
25,0000.0%0.00%
-25.0%
Q2 2016$84,000
+37.7%
25,0000.0%0.00%
+33.3%
Q1 2016$61,000
-25.6%
25,0000.0%0.00%
-25.0%
Q4 2015$82,00025,0000.00%
Other shareholders
NYMOX PHARMACEUTICAL CORP shareholders Q4 2020
NameSharesValueWeighting ↓
First Citizens Financial Corp 35,100$89,0000.08%
Geier Asset Management, Inc. 35,000$91,0000.07%
Patriot Financial Group Insurance Agency, LLC 43,250$107,0000.03%
Willow Creek Wealth Management Inc. 24,224$60,0000.02%
WEBSTER BANK, N. A. 70,000$174,0000.02%
Brown Advisory Securities, LLC 28,000$69,0000.01%
Cubic Asset Management, LLC 11,250$28,0000.01%
Tower Research Capital LLC (TRC) 25,613$64,0000.00%
GOFEN & GLOSSBERG LLC /IL/ 25,000$62,0000.00%
Sterling Investment Advisors, Ltd. 2,500$6,0000.00%
View complete list of NYMOX PHARMACEUTICAL CORP shareholders